While some systematic reviews find modest, specific symptomatic benefits of cannabinoids for conditions like insomnia, tics, or chronic pruritus, other high-quality reviews highlight inconsistent evidence, mixed trial outcomes, and a lack of robust support for many proposed medical indications.
The evidence we hold leans evenly split
How this was weighed
official record 3x · fact-check 2x · hedged 1x · crowd & reference 1x
The efficacy and safety of cannabinoids for the treatment of · peer-reviewed · supports · weight 1.05 · 2026
Cannabis and cannabinoids in dermatology: a systematic revie · peer-reviewed · supports · weight 1.05 · 2025
Therapeutic Use of Medical Cannabis Beyond Pain Management i · peer-reviewed · supports · weight 1 · 2026
Efficacy, effectiveness and safety of medical cannabis in PT · peer-reviewed · refutes · weight 1 · 2026
Cannabinoids and opioid consumption in cancer pain: a system · peer-reviewed · refutes · weight 1 · 2026
Evidence for · 3
The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis.
2026 · cited by 4
A systematic review and meta-analysis found that cannabinoids can reduce certain symptoms such as cannabis withdrawal, insomnia, tics, and autistic traits.
Evidence against · 3
Higher THC Concentration Medicinal Cannabis Products Efficacy and Safety Considerations: A Rapid Review.
2026 · cited by 2
A rapid review found mixed outcomes and noted a lack of high-quality evidence regarding the efficacy of higher THC medicinal cannabis products.
See more details
More for · 2
Cannabis and cannabinoids in dermatology: a systematic review and meta-analysis of quantitative outcomes
2025 · cited by 2
A meta-analysis of dermatologic conditions showed a statistically significant reduction in pruritus with cannabinoid treatments.
Therapeutic Use of Medical Cannabis Beyond Pain Management in Physical Medicine and Rehabilitation.
2026 · cited by 0
A review in physical medicine and rehabilitation noted modest benefits in symptom reduction for spasticity, seizure disorders, and sleep disturbances.
More against · 2
Efficacy, effectiveness and safety of medical cannabis in PTSD: a scoping review.
2026 · cited by 0
A scoping review concluded that current high-quality RCT evidence remains insufficient to support the clinical use of cannabinoids for PTSD.
Cannabinoids and opioid consumption in cancer pain: a systematic review and meta-analysis.
2026 · cited by 0
A systematic review and meta-analysis found that cannabinoids are not associated with consistent or clinically meaningful opioid-sparing effects in cancer pain under controlled conditions.